GALNT14-rs9679162 genotype is a predictor of PFS, OS, and response to FMP chemotherapy FMP in HCC, and GALNT14 expression also affects chemoresistance in breast and ovarian cancer cells. This evidence concerns the gene GALNT14 and ovarian carcinoma.